Andrea Kasinski’s lab is developing a longer-lasting microRNA-34a designed to suppress multiple cancer-driving genes.

Like tiny superheroes, small, naturally occurring segments of RNA can block multiple molecular paths that cancer cells use to ...

Armatus has published data in Molecular Therapy Nucleic Acids describing TVR110, a first-in-class vectorized microRNA for CMT1A.

A diagnostic panel incorporating let-7a-5p, miR-9-5p, and miR-31-5p achieved an area under the curve of 0.862 in differentiating patients with pulmonary arterial hypertension from healthy people.

Researchers have identified microRNA-93 as a key genetic driver of fatty liver disease and discovered that vitamin B3 can effectively shut it down. This finding suggests a safe, widely available ...

International Research Discovers Potential Cure For Fatty Liver. In a major breakthrough and providing a powerful treatment for millions around the world, an international team of researchers have ...

Innovative diagnostics may reduce ~9-year diagnosis delay, but systemic barriers to implementation remain.

Researchers have discovered that a tiny molecule, known as microRNA-93 (miR-93), is the primary driver of fatty liver disease ...

A new study suggests Vitamin B3 may help reverse fatty liver disease by targeting microRNA-93, which drives fat buildup. By ...

PrimeC into a late-stage clinical asset with FDA-cleared Phase 3 program in ALS -- Statistically significant survival benefit demonstrated, including 65% reduction in risk of death and >14-month ...

An experimental oral therapy was well-tolerated and linked to lower risks for ALS complications, according to findings of a phase 2b randomized controlled trial published in JAMA Neurology.“The ...